Why Lobo Technologies Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket
Lobo Technologies shares surged 32% premarket after a narrower H1 loss and higher sales; several small caps rallied while others fell sharply.
Economy · News reference
Top 3 Financial Stocks That May Fall Off A Cliff This Quarter
Three financial stocks—MarketAxess, Avalanche Treasury and Katapult—show overbought RSI readings above 70, warning momentum-focused investors.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K filing — Avalanche Treasury Corp (AVAT)
Filed: 2026-09-09 AccNo: 0001104659-26-106101 Size: 278 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Shares of banks and financial services companies are trading higher as softer oil prices have driven a decline in Treasury yields, helping ease inflation concerns and support expectations for a more favorable rate environment. The improved macro backdrop has lifted sentiment across the financial sector.
Shares of financial companies are trading lower. The sector may be under pressure as traders rotate into the tech space after recent e-commerce and payments partnerships with Meta's Muse AI agent threaten to disrupt traditional financial companies.
Katapult Holdings Files Prospectus Registering Up to 74,025,322 Shares Of Common Stock For Resale
Up to 74,025,322 Shares of Common StockThis prospectus relates to the offer and sale from time to time by the selling stockholders identified in this prospectus (the "Selling Stockholders") of up to 74,025,322
Roivant Sciences, Pharvaris, IonQ And Other Big Stocks Moving Higher On Tuesday
U.S. stocks fell Tuesday, but Roivant surged 16% on positive PH-ILD trial data. Pharvaris, Solaris, IonQ and quantum stocks also posted strong gains.